Greiner JW - Search Results

1

Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.

Zaharoff DA, Hance KW, Rogers CJ, Schlom J, Greiner JW. Zaharoff DA, et al. Among authors: greiner jw. J Immunother. 2010 Sep;33(7):697-705. doi: 10.1097/CJI.0b013e3181eb826d. J Immunother. 2010. PMID: 20664357 Free PMC article.

2

Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination.

Zaharoff DA, Rogers CJ, Hance KW, Schlom J, Greiner JW. Zaharoff DA, et al. Among authors: greiner jw. Vaccine. 2007 Mar 1;25(11):2085-94. doi: 10.1016/j.vaccine.2006.11.034. Epub 2006 Dec 4. Vaccine. 2007. PMID: 17258843 Free PMC article.

3

Chitosan solution enhances the immunoadjuvant properties of GM-CSF.

Zaharoff DA, Rogers CJ, Hance KW, Schlom J, Greiner JW. Zaharoff DA, et al. Among authors: greiner jw. Vaccine. 2007 Dec 17;25(52):8673-86. doi: 10.1016/j.vaccine.2007.10.037. Epub 2007 Nov 5. Vaccine. 2007. PMID: 18037196 Free PMC article.

4

The antitumor and immunoadjuvant effects of IFN-alpha in combination with recombinant poxvirus vaccines.

Hance KW, Rogers CJ, Zaharoff DA, Canter D, Schlom J, Greiner JW. Hance KW, et al. Among authors: greiner jw. Clin Cancer Res. 2009 Apr 1;15(7):2387-96. doi: 10.1158/1078-0432.CCR-08-1752. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276249 Free PMC article.

5

Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12.

Zaharoff DA, Hoffman BS, Hooper HB, Benjamin CJ Jr, Khurana KK, Hance KW, Rogers CJ, Pinto PA, Schlom J, Greiner JW. Zaharoff DA, et al. Among authors: greiner jw. Cancer Res. 2009 Aug 1;69(15):6192-9. doi: 10.1158/0008-5472.CAN-09-1114. Epub 2009 Jul 28. Cancer Res. 2009. PMID: 19638573 Free PMC article.

6

In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines.

Heffernan MJ, Zaharoff DA, Fallon JK, Schlom J, Greiner JW. Heffernan MJ, et al. Among authors: greiner jw. Biomaterials. 2011 Jan;32(3):926-32. doi: 10.1016/j.biomaterials.2010.09.058. Epub 2010 Oct 20. Biomaterials. 2011. PMID: 20965561 Free PMC article.

7

Immunization with a syngeneic tumor infected with recombinant vaccinia virus expressing granulocyte-macrophage colony-stimulating factor (GM-CSF) induces tumor regression and long-lasting systemic immunity.

McLaughlin JP, Abrams S, Kantor J, Dobrzanski MJ, Greenbaum J, Schlom J, Greiner JW. McLaughlin JP, et al. Among authors: greiner jw. J Immunother. 1997 Nov;20(6):449-59. doi: 10.1097/00002371-199711000-00004. J Immunother. 1997. PMID: 9409450

8

Identification of an interferon-gamma-inducible carcinoembryonic antigen (CEA) CD8(+) T-cell epitope, which mediates tumor killing in CEA transgenic mice.

Schmitz J, Reali E, Hodge JW, Patel A, Davis G, Schlom J, Greiner JW. Schmitz J, et al. Among authors: greiner jw. Cancer Res. 2002 Sep 1;62(17):5058-64. Cancer Res. 2002. PMID: 12208761

9

Vaccine-based therapy directed against carcinoembryonic antigen demonstrates antitumor activity on spontaneous intestinal tumors in the absence of autoimmunity.

Greiner JW, Zeytin H, Anver MR, Schlom J. Greiner JW, et al. Cancer Res. 2002 Dec 1;62(23):6944-51. Cancer Res. 2002. PMID: 12460911

10

Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice.

Zeytin HE, Patel AC, Rogers CJ, Canter D, Hursting SD, Schlom J, Greiner JW. Zeytin HE, et al. Among authors: greiner jw. Cancer Res. 2004 May 15;64(10):3668-78. doi: 10.1158/0008-5472.CAN-03-3878. Cancer Res. 2004. PMID: 15150127

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters